These findings highlight the critical involvement of these key genes in sepsis pathophysiology, suggesting that targeting MAPK14, CD82, TXN, NEDD4, and WIPI1 may offer promising therapeutic strategies for modulating ferroptosis, senescence, and immune responses to improve patient outcomes in sepsis. The gene discussed is CD82; the disease is Sepsis.